Paclitaxel- and/or cyclophosphamide-induced severe ischaemic retinopathy

Clin Exp Ophthalmol. 2020 Nov;48(8):1113-1115. doi: 10.1111/ceo.13854. Epub 2020 Sep 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms*
  • Cyclophosphamide / adverse effects
  • Female
  • Humans
  • Paclitaxel / adverse effects
  • Retinal Diseases* / chemically induced
  • Retinal Diseases* / diagnosis

Substances

  • Cyclophosphamide
  • Paclitaxel